Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Liminal Biosciences Inc
(NQ:
LMNL
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Sep 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
8.430 (1)
Ask (Size)
8.500 (25)
Prev. Close
8.500
Today's Range
N/A - N/A
52wk Range
8.370 - 8.500
Shares Outstanding
31,042,560
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 12, 2023
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
Via
Benzinga
Liminal BioSciences Stock Gains0% Today - Here's Why?
July 12, 2023
Liminal BioSciences Inc (NASDAQ: LMNL) shares are trading higher after Structured Alpha, a fund managed by Thomvest Asset Management, agreed to
Via
Benzinga
Performance
More News
Read More
Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
April 06, 2023
Via
Benzinga
Liminal BioSciences Pulls Plug On Its Lead Development Program
July 22, 2022
Via
Benzinga
Ocugen To Buy Liminal's Dormant Vaccine Manufacturing Plant In Canada
January 27, 2022
Via
Benzinga
Dow Rises 80 Points; MarketAxess Holdings Shares Slide
April 05, 2023
Via
Benzinga
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 05, 2023
Via
Benzinga
Liminal Biosciences Inc. (NASDAQ: LMNL) Leading the Way in Wednesday Trading Based on Percentage Gain
April 05, 2023
Via
Investor Brand Network
Topics
Derivatives
Exposures
Derivatives
Nasdaq Tumbles 150 Points; Liminal BioSciences Shares Spike Higher
April 05, 2023
Via
Benzinga
Why Is Freight Technologies (FRGT) Stock Up 25% Today?
April 05, 2023
Via
InvestorPlace
Why Is Liminal Biosciences (LMNL) Stock Up 77% Today?
April 05, 2023
Via
InvestorPlace
Markets Mixed; US Trade Deficit Widens In February
April 05, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 03, 2023
Via
Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 29, 2022
Via
Benzinga
Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset
July 22, 2022
Via
Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
August 09, 2022
Via
Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
July 25, 2022
Via
Benzinga
Liminal BioSciences Outlines Plans To Further Develop Its Lead Compound
March 14, 2022
Via
Benzinga
Americans’ Appetite for Vaccine Options Bodes Well for Ocugen
February 21, 2022
Via
InvestorPlace
Liminal BioSciences Pauses Development Of Fezagepras, Outlines R&D Priorities For 2022
January 20, 2022
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Via
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Via
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.